A look at prevention and treatment of diabetic retinopathy

2007 ◽  
Vol &NA; (1602) ◽  
pp. 3
Author(s):  
&NA;
Keyword(s):  
Diabetic Retinopathy ◽  
Prevention And Treatment

Prevention and Treatment of Diabetic Retinopathy: Evidence from Clinical Trials and Perspectives

2011 ◽  
Vol 7 (3) ◽  
pp. 190-200 ◽  
Author(s):  
Manuela Abbate ◽  
Paolo Cravedi ◽  
Ilian Iliev ◽  
Giuseppe Remuzzi ◽  
Piero Ruggenenti
Keyword(s):  
Clinical Trials ◽  
Diabetic Retinopathy ◽  
Prevention And Treatment

scholarly journals Use of Chlorogenic Acid against Diabetes Mellitus and Its Complications

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Yongwang Yan ◽  
Xu Zhou ◽  
Kangxiao Guo ◽  
Feng Zhou ◽  
Hongqi Yang
Keyword(s):  
Diabetes Mellitus ◽  
Diabetic Retinopathy ◽  
Diabetic Nephropathy ◽  
Peripheral Neuropathy ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Chlorogenic Acid ◽  
Pharmacological Properties ◽  
Prevention And Treatment ◽  
Main Component

Chlorogenic acid (CA) is a phenolic compound commonly found in human plant-based diets. CA is the main component of many traditional Chinese medicine preparations, and in recent years, it has been found to have hypoglycemic, hypolipidemic, anti-inflammatory, antioxidant, and other pharmacological properties. Specifically, CA relieves the effects of, and prevents, diabetes mellitus (DM). In addition, CA is also beneficial against complications arising from DM, such as diabetic nephropathy (DN), diabetic retinopathy (DR), and diabetic peripheral neuropathy (DPN). Herein, we review the use of CA in the prevention and treatment of DM and its complications, providing a background for further research and medical uses.

A systems modelling approach for the prevention and treatment of diabetic retinopathy

2003 ◽  
Vol 150 (1) ◽  
pp. 81-91 ◽  
Author(s):  
P.R. Harper ◽  
M.G. Sayyad ◽  
V. de Senna ◽  
A.K. Shahani ◽  
C.S. Yajnik ◽  
...  
Keyword(s):  
Diabetic Retinopathy ◽  
Prevention And Treatment ◽  
Systems Modelling ◽  
Modelling Approach

scholarly journals Diabetic Retinopathy: Mechanism, Diagnosis, Prevention, and Treatment

2015 ◽  
Vol 2015 ◽  
pp. 1-2 ◽  
Author(s):  
Mohamed Al-Shabrawey ◽  
Wenbo Zhang ◽  
Denise McDonald
Keyword(s):  
Diabetic Retinopathy ◽  
Prevention And Treatment

scholarly journals The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Wenjun Sha ◽  
Song Wen ◽  
Lin Chen ◽  
Bilin Xu ◽  
Tao Lei ◽  
...  
Keyword(s):  
Diabetic Retinopathy ◽  
Glucose Transporter ◽  
Early Stage ◽  
Sglt2 Inhibitor ◽  
Research Field ◽  
Research Progress ◽  
Diabetic Microangiopathy ◽  
Control Blood Glucose ◽  
Glucose Transporter 2 ◽  
Prevention And Treatment

Diabetic retinopathy (DR) is one of the most serious complications of diabetic microangiopathy. DR has an early onset and is not easy to detect. When visual impairment occurs, the optimal period for therapy is often missed. Therefore, the prevention and treatment of DR should start from the early stage of diabetes. Sodium-dependent glucose transporter 2 inhibitor (SGLT2i) is a new antidiabetic drug which is mainly used in clinical practice to control blood glucose of patients with type 2 diabetes prone to develop chronic heart failure. Recent studies have found that SGLT2 is also expressed in the human retina. Now, the prevention and treatment of diabetic retinopathy with SGLT2i while reducing blood sugar has become a new research field. Hence, this article reviewed the recent therapeutic and research progress of SGLT2 in the treatment of diabetic retinopathy.

scholarly journals Pathogenetic approaches to prevention and treatment of diabetic retinopathy

2017 ◽  
Vol 19 (4) ◽  
pp. 43-49
Author(s):  
O.V. Kolchik ◽  
◽  
S.V. Nemirova ◽  
K.S. Petrova ◽  
◽  
...  
Keyword(s):  
Diabetic Retinopathy ◽  
Prevention And Treatment
Sign in / Sign up

Export Citation Format

Share Document